Bradycardia Management and Assessment Quiz

Hyperthyroidism usually causes tachycardia, not bradycardia.

Bradycardia is typically defined as a heart rate less than 60 beats per minute in adults.

Untreated bradycardia can lead to atrial fibrillation as a potential complication.

The initial step in assessing a patient with suspected bradycardia is to assess airway, breathing, and circulation.

Palpitations are not commonly associated with bradycardia.

Atropine is commonly used for acute symptomatic bradycardia to increase heart rate.

Transcutaneous pacing is the primary intervention for symptomatic bradycardia with poor perfusion.

Sinus bradycardia is commonly associated with a normal sinus rhythm.

The primary treatment goal in managing bradycardia is to increase heart rate.

The parasympathetic nervous system primarily influences heart rate.

Stable bradycardia may be managed with observation and outpatient follow-up as the first-line treatment.

Beta-blockers are commonly used for the long-term management of bradycardia.

The recommended initial pacing rate for transcutaneous pacing in a bradycardic patient is 60-70 beats per minute.

Fatigue is a common symptom of bradycardia in athletes.

An echocardiogram can help identify the underlying cause of bradycardia, including structural heart disease.